|
Small Molecule Degraders for Targeting Transcription Factor Drivers of Childhood Cancers |
St. Jude Children’s Research Hospital |
The Swifty Foundation, Layla’s Legacy Foundation |
|
Targeting symmetric division in pediatric cancers |
Dana-Farber Cancer Institute |
The Swifty Foundation |
|
Targeting TGFb Pathway Dependencies in Group 3 Medulloblastoma |
University of California San Francisco |
The Swifty Foundation |
|
Exploring Synthetic Lethality of One-Carbon Metabolism Genes and mTORC1 Inhibition in MYCN Amplified Medulloblastoma |
University of California Berkeley |
The Swifty Foundation |
|
De-escalation of Radiotherapy for Medulloblastoma by a Novel DNA Damage Checkpoint Inhibitor |
Feinstein Institute for Medical Research - North Shore |
The Swifty Foundation |
|
Pre-clinical Testing of Novel Glutamine Metabolic Inhibitors in MYC-driven Medulloblastoma |
The Johns Hopkins University School of Medicine |
The Swifty Foundation |
|
Targeting Eya2 to Inhibit c-Myc driven Medulloblastoma Tumor Progression |
University of Colorado Denver |
The Swifty Foundation |
